Research Corporation Technologies
Research Corporation Technologies Demonstrates Long Half-Life of the CH2 Domain, a New Antibody-Derived Scaffold
Published in Pharma Business Week, July 23rd, 2012
2012 JUL 23 (NewsRx) -- By a News Reporter-Staff News Editor at Pharma Business Week -- Research Corporation Technologies (RCT) and the Protein Interactions Group of the National Cancer Institute at the National Institutes of Health (NIH) have published the first studies in primates that characterize the long half-life of isolated CH2 domains, a new antibody-derived scaffold. The work was performed under a Cooperative Research and Development Agreement (CRADA) between RCT and the NIH.
While therapeutic monoclonal antibodies are the most successful class of biologics in the last decade, their large size limits their ability to penetrate certain tissues and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Business Week
Source: Pharma Business Week (2012-07-23)
More Articles from Pharma Business Week
- Obesity
TMC institutions get $20 million renewal grant for translational medicine center - Pharmaceutical Companies
Study to test success of vision loss drug which could slash treatment costs for NHS - Medicinal Chemistry
Studies from National Institute of Biological Sciences Reveal New Findings on Medicinal Chemistry - Atorvastatin
Studies from Chung Ang University Have Provided New Data on Atorvastatin - Nanomaterials
Studies from Institute of Biophysics Add New Findings in the Area of Nanomaterials - Pharmaceutical Science
Studies from China Pharmaceutical University Have Provided New Information about Pharmaceutical Science - More from this issue of Pharma Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
